stockrowDexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.
- Revenue
- +11.2%
- EPS
- 0.00%
- Free cash flow
- −52.9%
- Total debt
- +0.31%
Quarter to September 2026, against a year earlier
Follow DXCM
Alert me
DexCom, Inc. (DXCM) Gross margin
DexCom, Inc.'s gross margin over the twelve months to 30 September 2026 was 63.4%, up 3.3 percentage points from fiscal 2025 (60.1%). Over the past ten years it has ranged from 60.1% (fiscal 2025) to 69.3% (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 60.1% | (0.36) |
| FY2024 | 60.5% | (2.73) |
| FY2023 | 63.2% | (1.53) |
| FY2022 | 64.7% | (3.91) |
| FY2021 | 68.6% | 2.19 |
| FY2020 | 66.4% | 3.33 |
| FY2019 | 63.1% | (1.25) |
| FY2018 | 64.4% | (4.13) |
| FY2017 | 68.5% | 2.49 |
| FY2016 | 66.0% | (3.25) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 64.3% | 0.85 |
| Jun 2026 | 63.4% | 0.49 |
| Mar 2026 | 63.0% | 0.02 |
| Dec 2025 | 62.9% | 2.45 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| EW Edwards Lifesciences Corporation compare | 78.0% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| BSX Boston Scientific Corporation compare | 69.1% |
| DXCM DexCom, Inc. | 63.4% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc compare | 44.6% |
| GEHC GE HealthCare Technologies Inc. compare | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on DXCM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement